Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Shares Outstanding (2016 - 2025)

Iradimed (IRMD) has disclosed Shares Outstanding for 13 consecutive years, with $12.8 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 0.57% to $12.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $12.8 million through Dec 2025, up 0.57% year-over-year, with the annual reading at $12.8 million for FY2025, 0.57% up from the prior year.
  • Shares Outstanding for Q4 2025 was $12.8 million at Iradimed, roughly flat from $12.7 million in the prior quarter.
  • The five-year high for Shares Outstanding was $12.8 million in Q4 2025, with the low at $12.3 million in Q1 2021.
  • Average Shares Outstanding over 5 years is $12.6 million, with a median of $12.6 million recorded in 2023.
  • The sharpest move saw Shares Outstanding increased 2.85% in 2021, then rose 0.27% in 2023.
  • Over 5 years, Shares Outstanding stood at $12.5 million in 2021, then increased by 0.37% to $12.6 million in 2022, then increased by 0.55% to $12.7 million in 2023, then grew by 0.39% to $12.7 million in 2024, then increased by 0.57% to $12.8 million in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $12.8 million, $12.7 million, and $12.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.